Antibiotics (content: μg slip-1)

Diameter of inhibiting ring (mm) (antibacterial activity)

A19008

A19010

CECT 4638

CAIM 1797

Tetracycline (30)

21.0 (S)

34.5 (S)

47.2 (S)

19.0 (S)

Oxytetracycline (30)

22.3 (S)

34.6 (S)

32.3 (S)

22.1 (S)

Doxycycline (30)

18.3 (S)

32.0 (S)

32.1 (S)

24.5 (S)

Kanamycin (30)

13.5 (R)

20.0 (S)

14.0 (I)

14.1 (I)

Gentamycin (10)

14.6 (I)

21.0 (S)

22.1 (S)

12.1 (I)

Norfloxacin (10)

21.3 (S)

27.4 (S)

14.2 (I)

14.2 (I)

Nalidixic acid (30)

12.0 (R)

18.9 (I)

35.7 (S)

18.1 (I)

Ciprofloxacin (5)

18.8 (I)

22.3 (S)

28.7 (S)

15.0 (I)

Oxacillin (1)

7.4 (R)

7.5 (R)

8.1 (R)

7.9 (R)

Ampicillin (10)

20.5 (R)

31.2(S)

27.9 (I)

23.1 (I)

Amoxicillin (30)

22.1 (S)

25.3 (S)

30.5 (S)

19.2 (S)

Erythromycin (15)

15.2 (I)

18.0 (I)

22.2 (I)

15.0 (I)

Sulfisoxazol (25)

20.3 (S)

30.1(S)

34.1 (S)

9.1 (R)

Enrofloxacin (5)

15.9 (I)

32.1 (S)

39.1 (S)

15.0 (S)

Chloramphenicol (30)

24.0 (S)

34.1 (S)

45.1 (S)

21.0 (S)

Nitrofurantoin (300)

19.2 (S)

23.1 (S)

34.1 (S)

14.1 (I)

Novobiocin (5)

10.7 (R)

24.2 (S)

34.2 (S)

18.0 (I)

S: Sensitive; I: Intermediate; R: Resistant
Table 3: Results of antibiotics susceptibility of Vibrio scophthalmi.